Most of the de novo BRCA1/2 mutations have been identified in patients with early-onset breast cancer and without family history of the disease. The identification of these alterations could play a prominent role in the prevention and treatment strategies and may influence clinical management of patients.
A new case of "de novo" BRCA1 mutation in a patient with early-onset breast cancer
ANTONUCCI, IVANA;PROVENZANO, MARTINA;RODRIGUES, MELISSA;PALKA, Giandomenico;STUPPIA, Liborio
2017-01-01
Abstract
Most of the de novo BRCA1/2 mutations have been identified in patients with early-onset breast cancer and without family history of the disease. The identification of these alterations could play a prominent role in the prevention and treatment strategies and may influence clinical management of patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
